ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Pirfenidone Tablets, 267 mg and 801 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of the Listing Regulations, 2015, we enclose herewith a copy of Notice w.r.t. transfer of Equity Shares of the Company to Investor Education and Protection Fund (IEPF) published in Indian Express (English edition) and Financial Express (Gujarati edition - vernacular language) on 21st May, 2022. We request you to kindly take the same on record. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the share certificate(s) of the Company has been reported as lost/misplaced and the registered shareholder(s) have requested the Company for issue of duplicate share certificate(s) as per enclosed letter. We enclose herewith an e-mail intimation(s) received from Link lntime India Private Limited, Registrar and Share Transfer Agent giving the proof of the date of receipt of aforesaid information by the Company. We request you to kindly take the same on record. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Specimen Of The Reminder Letter Dated 18Th May, 2022 Sent To The Relevant Shareholders
Pursuant to Regulation 30 of the Listing Regulations, 2015, we enclose herewith a specimen of the reminder letter dated 18th May, 2022 sent to the relevant shareholders for whom the dividend remains unpaid / unclaimed for seven or more consecutive years and whose shares are liable to be transferred to the Investor Education and Protection Fund ('IEPF') Authority as per Section 124(6) of the Companies Act, 2013 read with Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended from time to time. We request you to kindly take the same on record. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the share certificate(s) of the Company has been reported as lost/misplaced and the registered shareholder(s) have requested the Company for issue of duplicate share certificate(s) as per the enclosed letter. We enclose herewith an e-mail intimation(s) received from Link lntime India Private Limited, Registrar and Share Transfer Agent giving the proof of the date of receipt of aforesaid information by the Company. We request you to kindly take the same on record. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Disclosure On Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015
With reference to the captioned matter, we would like to inform that pending the release of XBRL template in the new format prescribed by SEBI vide its Circular dated 22nd November, 2021 on Disclosure obligations of listed entities in relation to Related Party Transactions and based on the verbal guidance provided by the stock exchanges, we enclose herewith scanned copy of disclosures on Related Party Transactions for the half year ended 31st March, 2022. We will upload the said disclosures in XBRL as and when the template is released by the stock exchanges. We request you to kindly take the same on record. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that the management of the Company will meet analyst(s) / investor(s) as per the details mentioned in the attached letter. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of the Listing Regulations, 2015, we enclose herewith a copy of the notice published in Indian Express (English edition) and Sandesh (Gujarati edition - vernacular language) on 13th May, 2022 informing the Equity Shareholders, Secured Creditors and Unsecured Creditors inter alia about the notice of separate meetings convened pursuant to the directions of Hon'ble National Company Law Tribunal, Ahmedabad Bench ('NCLT') through Video Conferencing or Other Audio Visual Means ('VC/OAVM'), dispatch of notice of meeting of Equity Shareholders, Secured Creditors and Unsecured Creditors and procedure for remote e-voting or e-voting at the time of relevant meeting. We request you to kindly take the same on record. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the share certificate(s) of the Company has been reported as lost/misplaced and the registered shareholder(s) have requested the Company for issue of duplicate share certificate(s). We enclose herewith an e-mail intimation(s) received from Link lntime India Private Limited, Registrar and Share Transfer Agent giving the proof of the date of receipt of aforesaid information by the Company. We request you to kindly take the same on record. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019, please find enclosed herewith the Annual Secretarial Compliance Report issued by M/s. Samdani Shah & Kabra, Practicing Company Secretaries, for the financial year ended 31st March, 2022. We request you to kindly take the same on record.